SCHEMBL413338

SCHEMBL413338

CCCCCCCCCCCC(=O)C(C)(CN)S(=O)(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FAAH O00519 11/20 0.47
▸ CES1 P23141 10/20 0.47
▸ CES2 O00748 5/20 0.47
▸ MEN1 O00255 2/20 0.47
▸ KMT2A Q03164 2/20 0.47
▸ HSD17B10 Q99714 2/20 0.47
▸ CYP1A2 P05177 1/20 0.47
▸ PPARG P37231 3/20 0.39
▸ PPARD Q03181 3/20 0.39
▸ PPARA Q07869 3/20 0.39
▸ TSHR P16473 2/20 0.39
▸ GPR84 Q9NQS5 2/20 0.39
▸ HDAC11 Q96DB2 2/20 0.39
▸ TDP1 Q9NUW8 2/20 0.39
▸ ALDH1A1 P00352 1/20 0.39
▸ SLC22A6 Q4U2R8 1/20 0.39
▸ SLC22A8 Q8TCC7 1/20 0.39
▸ TLR2 O60603 1/20 0.39
▸ ESR1 P03372 1/20 0.39
▸ FABP4 P15090 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL412965 1.00 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL413335 1.00 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL410606 1.00 FAAH (0.47) FAAHCES1CES2MEN1KMT2A
SCHEMBL1959306 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL22325578 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL1962801 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL2912760 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL2913821 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL1961718 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A
SCHEMBL1337430 0.98 FAAH (0.46) FAAHCES1CES2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 128 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115160995-B Viscosity reducer for drilling fluid and preparation method thereof 山东诺尔生物科技有限公司 2023-08-04 — — CN claimed
CN-110049756-B Oral composition 狮王株式会社 2023-04-04 — — CN claimed
CN-115160995-A Viscosity reducer for drilling fluid and preparation method thereof 山东诺尔生物科技有限公司 2022-10-11 — — CN claimed
CN-115135307-A Carrier for cell delivery 株式会社ITO 2022-09-30 — — CN claimed
WO-2021215423-A1 COSMETIC PREPARATION 株式会社 資生堂 (JP) 2021-10-28 — — WO claimed
CN-106309163-A Microcrystalline enzyme facial cleanser and preparation method thereof 上海铂源健康科技有限公司 2017-01-11 — — CN claimed
US-12559611-B2 Hydrophobic alginic acid particle group and method for producing same NISSHINBO HOLDINGS INC. (JP) 2026-02-24 — — US disclosed
US-12458578-B2 Composition for inhibiting plaque formation SUNSTAR SUISSE SA (CH) 2025-11-04 — — US disclosed
EP-4640751-A1 MARINE BIODEGRADABLE POLYMER PARTICLE GROUPS AND PRODUCTION METHOD FOR SAME Nisshinbo Holdings Inc. (JP) 2025-10-29 — — EP disclosed
US-12441850-B2 Amphiphilic alginic acid particle group and method for producing same NISSHINBO HOLDINGS INC. (JP) 2025-10-14 — — US disclosed
EP-4608908-A1 CARBOXYLATE SALTS OF AMINE COMPOUNDS AS CURING AGENTS Hexcel Corporation (US) 2025-09-03 — — EP disclosed
EP-4589066-A1 TREATMENT AGENT FOR ACRYLIC FIBERS AND USE OF SAME Matsumoto Yushi-Seiyaku Co., Ltd. (JP) 2025-07-23 — — EP disclosed
US-12359146-B2 Personal cleansing composition comprising a mixture of two polyglycerol fatty acid esters and a sugar fatty acid ester MERRY PLUS CORPORATION (JP) 2025-07-15 — — US disclosed
US-20070104659-A1 Capsule-containing oral composition SUNSTAR INC. (JP) 2007-05-10 — — US disclosed
EP-1693049-A1 CAPSULE-CONTAINING ORAL COMPOSITION Sunstar Inc. (JP) 2006-08-23 — — EP disclosed
EP-1669055-A1 DETERGENT COMPOSITION Asahi Kasei Chemicals Corporation (JP) 2006-06-14 — — EP disclosed
CN-1469731-A Multi-phase separating personal wash composition in transparent or translucent package — 2004-01-21 — — CN disclosed
EP-0461593-B1 Hair cleansing composition KAO CORP (JP) 1996-09-11 — — EP disclosed
EP-0687721-A2 Detergent composition Ajinomoto Co., Inc. (JP) 1995-12-20 — — EP disclosed
US-5342611-A Surfactant, alcohol, water and liquid oil; viscosity ratio KAO CORPORATION (JP) 1994-08-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12458578-B2 Composition for inhibiting plaque formation CAPG, CETP, APOB FAAH 869/4885CES1 1157/4885CES2 3055/4885
US-12559611-B2 Hydrophobic alginic acid particle group and method for producing same ALG3, ALG1, HACD3 FAAH 2324/4885CES1 3472/4885CES2 3691/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback